Further analyses demonstrated that ERG, a transcription factor, could bind to site 1 of the ICAM2 promoter region to promote ICAM2 transcription, which potentiated the cancer-inhibitory effect of ICAM2. This evidence concerns the gene ICAM2 and cancer.